CoChat

Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine

Open access
Nardi, A.E., Valença, A.M., Freire, R.C., Mochcovitch, M.D., Amrein, R., Sardinha, A., Levitan, M.N., Nascimento, I., de-Melo-Neto, V.L., King, A.L., de O. e Silva, A.C., Veras, A.B., Dias, G.P., Soares-Filho, G.L., da Costa, R.T., Mezzasalma, M.A., de Carvalho, M.R., de Cerqueira, A.C., Hallak, J.E., Crippa, J.A., Versiani, M. · 2011 · Brazilian Journal of Medical and Biological Research
Cited by 39

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

The objective of the present randomized, open-label, naturalistic 8-week study was to compare the efficacy and safety of treatment with clonazepam (N = 63) and paroxetine (N = 57) in patients with panic disorder with or without agoraphobia. Efficacy assessment included number of panic attacks and clinician ratings of the global severity of panic disorders with the clinical global impression (CGI) improvement (CGI-I) and CGI severity (CGI-S) scales. Most patients were females (69.8 and 68.4% in the clonazepam and paroxetine groups, respectively) and age (mean ± SD) was 35.9 ± 9.6 years for the clonazepam group and 33.7 ± 8.8 years for the paroxetine group. Treatment with clonazepam versus paroxetine resulted in fewer weekly panic attacks at week 4 (0.1 vs 0.5, respectively; P < 0.01), and greater clinical improvements at week 8 (CGI-I: 1.6 vs 2.9; P = 0.04). Anxiety severity was significantly reduced with clonazepam versus paroxetine at weeks 1 and 2, with no difference in panic disorder severity. Patients treated with clonazepam had fewer adverse events than patients treated with paroxetine (73 vs 95%; P = 0.001). The most common adverse events were drowsiness/fatigue (57%), memory/concentration difficulties (24%), and sexual dysfunction (11%) in the clonazepam group and drowsiness/fatigue (81%), sexual dysfunction (70%), and nausea/vomiting (61%) in the paroxetine group. This naturalistic study confirms the efficacy and tolerability of clonazepam and paroxetine in the acute treatment of patients with panic disorder.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1590/s0100-879x2011000400015

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 39

Metadata

Authors
Nardi, A. E., Valença, A. M., Freire, R. C., Mochcovitch, M. D., Amrein, R., Sardinha, A., Levitan, M. N., Nascimento, I., de-Melo-Neto, V. L., King, A. L., de O. e Silva, A. C., Veras, A. B., Dias, G. P., Soares-Filho, G. L., da Costa, R. T., Mezzasalma, M. A., de Carvalho, M. R., de Cerqueira, A. C., Hallak, J. E., Crippa, J. A., & Versiani, M.
Venue
Brazilian Journal of Medical and Biological Research
Published
2011-04
Volume
44
Issue
4
Pages
366-373
ISSN
  • 0100-879X (ISSN-L)
  • 1414-431X
OpenAlex
W4247026698
Cited by
39
References
4
FWCI
3.95
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine. https://app.cochat.ai/papers/10.1590/s0100-879x2011000400015
The paper
Nardi, A. E., Valença, A. M., Freire, R. C., Mochcovitch, M. D., Amrein, R., Sardinha, A., Levitan, M. N., Nascimento, I., de-Melo-Neto, V. L., King, A. L., de O. e Silva, A. C., Veras, A. B., Dias, G. P., Soares-Filho, G. L., da Costa, R. T., Mezzasalma, M. A., de Carvalho, M. R., de Cerqueira, A. C., Hallak, J. E., . . . Versiani, M. (2011). Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine. Brazilian Journal of Medical and Biological Research. https://doi.org/10.1590/s0100-879x2011000400015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.